63,644 Shares in NanoViricides, Inc. (NYSE:NNVC) Bought by Virtu Financial LLC

Virtu Financial LLC bought a new position in shares of NanoViricides, Inc. (NYSE:NNVC) during the 4th quarter, Holdings Channel.com reports. The firm bought 63,644 shares of the company’s stock, valued at approximately $91,000.

Separately, Integrated Wealth Concepts LLC increased its holdings in shares of NanoViricides by 44.8% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 53,335 shares of the company’s stock valued at $80,000 after acquiring an additional 16,500 shares during the last quarter. Institutional investors and hedge funds own 10.30% of the company’s stock.

NanoViricides Stock Performance

Shares of NNVC stock opened at $1.21 on Monday. The company has a market capitalization of $18.93 million, a price-to-earnings ratio of -1.68 and a beta of 1.14. The stock’s 50 day simple moving average is $1.25 and its 200 day simple moving average is $1.37. NanoViricides, Inc. has a twelve month low of $1.03 and a twelve month high of $3.59.

NanoViricides Profile

NanoViricides, Inc, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-CoV-2, nanoviricide drug which is in phase 1a/1b clinical trails for the treatment of Covid; and NV-CoV-2 Oral Syrup, and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric cases.